AIM ImmunoTech (AIM) Institutional Ownership $0.20 +0.02 (+11.19%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for AIM ImmunoTech (NYSE:AIM)CurrentInstitutional OwnershipPercentage12.02%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.52MNumber ofInstitutional Sellers(last 12 months)0 Get AIM Insider Trade Alerts Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AIM Institutional Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! AIM ImmunoTech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC4,078,000$1.52M0.0%N/A7.919% 11/16/2021 Verition Fund Management LLC148,479$300K0.0%+37.5%0.310% 11/15/2021 HighTower Advisors LLC41,095$82K0.0%-38.8%0.086% 10/28/2021 WINTON GROUP Ltd82,564$167K0.0%+50.4%0.173% 10/19/2021 Arkadios Wealth Advisors21,597$43K0.0%N/A0.045% 8/17/2021 Bridgeway Capital Management LLC246,000$529K0.0%-9.2%0.514% Get the Latest News and Ratings for AIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AIM ImmunoTech and its competitors with MarketBeat's FREE daily newsletter. 8/16/2021 Schonfeld Strategic Advisors LLC23,100$49K0.0%-40.0%0.048% 8/16/2021 State Street Corp160,413$345K0.0%N/A0.335% 8/13/2021 Renaissance Technologies LLC152,848$329K0.0%-68.1%0.320% 8/13/2021 Northern Trust Corp87,226$188K0.0%+28.8%0.182% 8/13/2021 Vanguard Group Inc.1,993,156$4.29M0.0%+3.5%4.167% 8/12/2021 XTX Topco Ltd29,269$63K0.0%N/A0.061% 8/12/2021 Dimensional Fund Advisors LP139,160$299K0.0%N/A0.291% 8/10/2021 WINTON GROUP Ltd54,894$118K0.0%N/A0.115% 6/4/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 5/19/2021Virtu Financial LLC29,484$67K0.0%-71.6%0.062% 5/18/2021 Verition Fund Management LLC108,000$245K0.0%+80.0%0.226% 5/18/2021 Morgan Stanley2,505,954$5.69M0.0%+150.9%5.240% 5/18/2021 Citadel Advisors LLC103,283$234K0.0%N/A0.216% 5/17/2021 Schonfeld Strategic Advisors LLC38,500$88K0.0%N/A0.081% 5/13/2021 Renaissance Technologies LLC478,759$1.09M0.0%N/A1.001% 5/12/2021 Geode Capital Management LLC351,750$798K0.0%+49.7%0.736% 5/11/2021 Rockefeller Capital Management L.P.40,000$90K0.0%+100.0%0.084% 5/10/2021 HighTower Advisors LLC63,095$143K0.0%N/A0.132% 5/10/2021 GSA Capital Partners LLP74,790$170K0.0%+338.7%0.156% 5/7/2021BlackRock Inc.979,042$2.22M0.0%+91.7%2.047% 5/7/2021 Cambridge Investment Research Advisors Inc.46,679$106K0.0%+14.7%0.098% 5/4/2021 Community Bank N.A.13,226$30K0.0%N/A0.028% 4/21/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 2/24/2021Virtu Financial LLC103,807$186K0.0%+250.7%0.255% 2/18/2021 Verition Fund Management LLC60,000$107K0.0%+50.0%0.147% 2/5/2021BlackRock Inc.510,796$914K0.0%+1.6%1.255% 2/4/2021 Cambridge Investment Research Advisors Inc.40,679$73K0.0%+19.0%0.100% 2/4/2021 GSA Capital Partners LLP17,047$31K0.0%-82.2%0.042% 12/11/2020Virtu Financial LLC29,604$64K0.0%-55.5%0.073% 11/13/2020 Morgan Stanley805,415$1.73M0.0%+69.1%2.029% 11/12/2020 JPMorgan Chase & Co.17,369$37K0.0%+868,350.0%0.044% 11/10/2020 Arkadios Wealth Advisors20,000$45K0.0%N/A0.050% 11/9/2020 LPL Financial LLC20,500$44K0.0%N/A0.052% 11/6/2020BlackRock Inc.502,692$1.08M0.0%+5.7%1.267% Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details.11/6/2020 GSA Capital Partners LLP95,754$206K0.0%N/A0.241% 10/29/2020 Cambridge Investment Research Advisors Inc.34,179$73K0.0%N/A0.086% (Data available from 1/1/2016 forward) AIM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AIM shares? During the previous two years, the following institutional investors and hedge funds held shares of AIM ImmunoTech shares: Armistice Capital LLC ($1.52M).Learn more on AIM's institutional investors. What percentage of AIM ImmunoTech stock is owned by institutional investors? 12.02% of AIM ImmunoTech stock is owned by institutional investors. Learn more on AIM's institutional investor holdings. Which institutional investors have been buying AIM ImmunoTech stock? The following institutional investors have purchased AIM ImmunoTech stock in the last 24 months: Armistice Capital LLC ($4.08M). How much institutional buying is happening at AIM ImmunoTech? Institutional investors have bought a total of 4,078,000 shares in the last 24 months. This purchase volume represents approximately $1.52M in transactions. Related Companies GANX Major Shareholders CALC Major Shareholders SCYX Major Shareholders ATNM Major Shareholders ACHL Major Shareholders OCX Major Shareholders BLRX Major Shareholders RVPH Major Shareholders OMGA Major Shareholders ITRM Major Shareholders This page (NYSE:AIM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIM Stock Alerts